Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;5(2):61-5.
doi: 10.5681/jcvtr.2013.013. Epub 2013 Jun 27.

Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways

Pouran Karimi  1 , Nadereh Rashtchizadeh
Affiliations

Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways

Pouran Karimi et al. J Cardiovasc Thorac Res. 2013.

Abstract

Introduction: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative stress and thrombotic agents. This study aimed to evaluate the potential role of cupper oxidized low-density lipoprotein (OxLDL) and thrombin for inducing mitogen activated protein kinases (MAPKs) in platelets.

Methods: Phosphorylation of P38MAPK, Jun N-terminal Kinase (JNK), and Extracellular signal-regulated kinases (ERK1/2) and P-selectin expression were determined in lysates of washed human platelets pretreated with low doses of thrombin and cu2+-OxLDL By Enzyme-linked immunosorbent assay (ELISA). Pharmacological inhibition was performed by SB203580, PD980559 and SP6000125 for P38MAPK, ERK1/2 and JNK activity, respectively. The ratio of phosphorylated to total protein was used for normalizing the phospho proteins contents of cells.

Results: OxLDL and thrombin significantly and differentially increased P-selectin expression (P<0.05), P38MAPK (P<0.05) and c-JNK (P<0.05) and ERK1/2 (P<0.05) phosphorylation in platelets. SB 203580 and SP6000125 significantly decreased P-selectin expression in both oxidative (P<0.05) and thrombotic (P<0.05) activated platelets.

Conclusion: Our results indicated that MAPK inhibitors can reduce atherothrombotic events via alterations in P-selectin expression suggesting that these inhibitors may be useful in the inhibition of atheroma development.

Keywords: Atherosclerosis; C-Jun N-terminal Kinase Extracellular; P-selectin; P38-Mitogen Activated Protein Kinase; Signal-regulated Kinase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
See this image and copyright information in PMC

References

    1. Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold forhumans? . Trends Cardiovasc Med . 2001;11: 93–102. - PubMed
    1. Daub K, Lindemann S, Langer H, Seizer P, Stellos K, Siegel-Axel D. et al. The evil in atherosclerosis: adherent platelets induce foam cell formation. Semin Thromb Hemost . 2007;33:173–8. - PubMed
    1. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nature Reviews . 2006; 6:532–40. - PubMed
    1. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol . 2004;4:372–77. - PubMed
    1. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC. Novel homologues of CSBP/p38 MAP kinase. Biochem Biophys Res Comm . 1997;235:533–8. - PubMed

LinkOut - more resources